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ABSTRACT
For years, natural polymers have played a significant role in pharmaceutical field due to their
biocompatibility and biodegradability. In Indonesia, most research in natural polymers focus
on application of the polymers as inert pharmaceutical excipients or as drug matrix in micro- and
nano- particle. Meanwhile, research about polymers in the world (mostly synthetic polymers) have
been progressed to advanced drug delivery system. In this system, the polymer can act as either
pharmacologically active molecules, or sophisticated carrier in targeted prodrug delivery system.
The latter is called polymer-drug conjugates, a system where the drugs are covalently attached to a
polymeric carrier, rather than simply entrapped in polymer matrix. Natural polymers have been one of
the materials to use for the carrier due to their biocompatibility and biodegradability. This review article
emphasizes the opportunity, challenges and strategies to use natural polymers as carrier in polymerdrug conjugates. Moreover, we also discuss some aspects in regards of the synthesis and analysis,
to give some perspectives and encouragement for the Indonesian researcher who are interested in
exploring this research field.
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INTRODUCTION
Natural polymers have been extensively used in research
and development of pharmaceutical products. Their
applications are mostly on the use of the polymers as
excipient in pharmaceutical dosage form. In the last
8 years, research in natural polymer in Indonesia are
mainly about modifying the polymer to increase the
performance as matrix in controlled release tablets and
capsules (Ariani, Surini, & Hayun, 2016; Surini, Nizma,
& Azizahwati, 2017; Surini, Wati, & Syahdi, 2018)
gastroretentive drug delivery system (Budianto, AlShidqi, & Cahyana, 2017; Dessy, Siahaan, & Bangun,
2018), mucoadhesive system (Adliani & Bangun,
2016; Arianto, Bangun, Harahap, & Ilyas, 2015; Putri,
Sulistomo, & Surini, 2017), microsphere (Hariyadi et al.,
2014) and microcapsule (Halim, Arianti, & Umar, 2011).
In those cases, the polymers are supposed to be inert and
do not chemically interact with the loaded drugs.
Some research in Indonesia also encompassed the use
of natural polymer as nanoparticle. Martien, Sa’adah,
& Saifullah (2016) synthesized insulin-loaded chitosanpectin nanoparticles via ionic gelation method for oral
delivery of insulin. Pertiwi, Martien, Sismindari, &
Ismail (2018) also used chitosan-pectin nanoparticle
to encapsulate Ribosome Inactivating Protein isolated
from Mirabilis jalapa L., with particle size ~350 nm.
Chitosan nanoparticles were also used to encapsulate
Phaleria macrocarpa leaf extract for suppression of

mitosis and hyperplasia in small intestine crypt epithelial
cells (Kusmardi, Ramadhan Tamzir, Widiasari, &
Estuningtyas, 2018).
Meanwhile, research about polymer worldwide has
progressed to more advanced drug delivery system
called polymer therapeutic. Unlikely application of
polymers only as inert excipients in conventional dosage
forms, polymer therapeutic require covalent attachment
between drug and polymer to form new system which
is considered as new drug. Polymer therapeutic diverse
to some different systems, including polymeric drug,
polymer-drug conjugates, polymer-protein conjugate,
self-assembly polymeric micelles and many more
(Duncan & Vicent, 2013). Some products of polymer
therapeutic have reached the market and some are still
in clinical trials (Atkinson, Andreu, & Vicent, 2018;
Duncan, 2017). Surprisingly, two compounds of this
therapeutic group, the white blood cell booster Neulasta®
and the immunomodulatory drug Copaxone®, became
Top 10 selling drugs in US (Atkinson et al., 2018;
Duncan, 2014).
In Indonesia, research in polymer therapeutic is slightly
explored. Dendrimers become the most popular
“polymer” being used as carrier, either for cytotoxic
drugs (Sagita, Djajadisastra, & Mutalib, 2016) or
theranostic agents such as 198Au (Halid, Sutriyo, Mutalib,
Pujiyanto, & Gunawan, 2017) and radiogadolinium
(III) (Rahmania, Mutalib, Ramli, & Levita, 2015).
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Nevertheless, research in this area using natural polymer
has not been found in any international publications
(searching was filtered by affiliation “Indonesia”).
Therefore, we would like to give some concepts about
polymer therapeutics using natural polymer as carrier.
We are interested in using natural polymer due to
Indonesia’s biodiversity of natural polymer resources
that can be explored, such as dextrin, chitosan and pectin.
Besides, their biodegradability and biocompatibility
provide certain benefits. In this review, we focus only
on polymer-drug conjugates since they are relatively
simpler than other systems in polymer therapeutic
cluster. This review will cover the definition of polymerdrug conjugates, design of the system and some aspects
on synthesis and analysis.
Overview of Polymer-Drug Conjugates
Ringsdorf’s Model
Polymer-drug conjugates (PDC) refer to systems which
consist of polymer as carrier and covalently-attached
small molecule drugs (Vicent & Duncan, 2006). This
covalent link is able to provide clinical benefits such
as alteration in the pharmacokinetics (Danson et al.,
2004; Forrest et al., 2008; Šírová et al., 2017; Vasey et
al., 1999) and even improve biodistribution of several
cancer drugs (Ernsting, Tang, MacCallum, & Li, 2012;
H. Tang et al., 2018). Because of some alterations in
biological behavior, this system is considered as New
Chemical Entity (NCE) and should undergo full phase of
clinical trial (Atkinson et al., 2018).
Ringsdorf’s model is the generic concept of polymer-drug
conjugates design with lysosomotropic system, which
was established in 1975 by Helmut Ringsdorf (Ringsdorf,
1975). N-(2-hydroxypropyl) methacrylamide (HPMA)doxorubicin conjugate was the first to enter Phase 1/II
clinical trials in 1994 (Duncan & Vicent, 2013). This
then became the prototype for HPMA-based polymer
conjugates.

Figure 1. Ringdorf's Model for Polymer-drug
Conjugates System
ISSN 2407-2354

Sagita, et al.

In Ringsdorf’s model (Figure 1), the system consists
of polymer carrier, linker, and conjugated molecules.
The conjugated molecules can be drugs, targeting
moieties, or labelling molecules such as fluorophore
and radioisotope. The covalent conjugation brings
superiorities such as higher drug loading, controlled drug
release and minimization of undesirable drug leaking,
compared to physically encapsulated polymer systems
(Pang et al., 2016).
Advantages of Polymer-Drug Conjugates: Role of
Polymeric Carrier
Conjugating poorly soluble drugs to hydrophilic
polymer can improve the solubility of the drugs. For
example, paclitaxel-poly-L-glutamic acid conjugates
could be dissolved in normal saline, while the free
paclitaxel required mixture of 50:50 Cremophor-ethanol
and saline (1:4), for the equivalent amount of paclitaxel
(Li et al., 1998). Solubility of saquinavir can also be
enhanced by conjugation with polyethyleneglycol (PEG)
(Gunaseelan et al., 2004). Another example is solubility
improvement of a xantin oxidase inhibitor, 4-amino6-hydroxypyrazolo[3,4-d]pyrimidine (AHPP), when
conjugated with styrene maleic acid copolymer (SMA)
(Fang et al., 2009).
The other advantage of PDC is prolonged plasma
half-life due to their nano-sized compared to the free
parent drugs. Depend on the length and shape of the
polymeric carrier, the hydrodynamic size can range
from 5 to 200 nm. This size is above the limit of renal
filtration, which is varied by size but is around 3.5 nm
(Nishiyama, 2007) and therefore reduce the excretion of
the conjugates. Moreover, we can decorate the system
with polyethylene glycol (PEGylation) that act as a
“shield” and reduce the interaction with phagocytic
cells. However, the superiority of PEG for drug delivery
system is being questioned, since numerous studies
found that PEGylation causes enhanced serum protein
binding and anti-PEG antibody production (see review
from Verhoef & Anchordoquy, 2013). A new study
demonstrated increase anti-PEG antibody production in
healthy wildtype mice after subsequent administration
of PEGylated polymeric nanoparticles and liposomes
(Grenier, de Oliveira Viana, Lima, & Bertrand, 2018)
However, the linear PEG alone was less immunogenic.
The authors suggested alternative PEGylation strategies
for future study, for example polymer chains with comb
architectures, to change the pattern of PEG layer on
polymers.
Polymer-drug conjugates, as part of nanomedicine,
has been extensively explored for improving cancer
therapy by their well-known enhanced permeability and
retention (EPR) characteristic. The phenomenon is due
to increase permeability of tumor vasculature that makes
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macromolecules larger than 40 kDa can extravasate
and accumulate in tumor tissues, as well as improper
lymphatic function that reduce the disposal of such
materials to lymphatic system (Fabienne Danhier, Feron,
& Préat, 2010; Fang, Nakamura, & Maeda, 2011). This
is then popularly called passive targeting.
The EPR concept is now a controversy because of the
heterogeneity of tumor cells (F. Danhier, 2016; Maeda,
2015). However, conjugation of anticancer drugs to
nanoparticles or polymer has proved reduced toxicity
to normal tissues (Ernsting et al., 2012; Lammers et
al., 2009; H. Tang et al., 2018). Therefore, research
in polymer-drug conjugates still need to be explored,
especially with natural polymers, as they are considered
as biocompatible. Moreover, current application of
polymeric nanoparticles is not only for cancer therapy
but also other diseases such as antiinfectives, tissue
regeneration and repair, wound healing, osteoarthritis,
rheumatoid arthritis, ischemia, and many more (Duncan
& Vicent, 2013).
Drug Release from Conjugate
So if the drugs are covalently attached to the carrier, how
can the drugs give the same pharmacological effect?
This is where the “linker” or “spacer” plays a role. As
we can see in Ringsdorf’s model, the drug is linked to
the polymer via a spacer. The linker/spacer should be
made selectively degradable, which means it will not be
cleaved in the systemic circulation, but it will undergo
cleavage when it reaches the site of action to release the
drugs. This condition may be induced by differences in
the environment condition between blood circulation
and site of action such as pH and the presence of specific
enzyme. Kurtoglu, Mishra, Kannan, & Kannan (2010)
observed different drug release characteristics from
dendrimer with different linkers, and found that amide
linkers were very stable at all pH, while ester and peptide
linkers showed pH dependent and enzyme-activated
rates, respectively.
Drug release by pH-dependent hydrolysis provides
benefit for delivery of anticancer drugs, because tumor
microenvironment has more acid pH (6.0-7.0) than
normal plasma (7.4) (Fabienne Danhier et al., 2010).
Furthermore, the inside of lysosomes, cell organelles
that digest engulfed foreign particle, have pH 4.0-5.0
(DiCiccio & Steinberg, 2011), which facilitate rapid
release of drugs inside the cells. Cisplatin was conjugated
to modified PEG polymer via ester bond and showed
different drug release profile in vitro at pH 5.0, 6.0 and
7.4 (Aryal, Hu, & Zhang, 2010). Hydrazone linkage was
used to attached paclitaxel to HPMA copolymer (Etrych,
Milada, Starovoytova, Blanka, & Ulbrich, 2010). The
conjugates were relatively stable at the pH of blood (7.4)
and release active drug in pH 5. Du, Du, Mao, & Wang
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(2011) also used hydrazine bond to link doxorubicin to
polymer.
Enzyme-activated linker involves cleavable peptide
sequences that are sensitive to specific enzymes such as
cathepsins, matrix metalloproteases (MMPs), plasmin,
prostate-specific antigen (PSA) and urokinase (Wong
& Choi, 2015). Conjugation of paclitaxel and PEG via
valine–citrulline dipeptide linker showed higher in vitro
drug release in the existence of Cathepsin B than without
the enzyme (Liang et al., 2012). GLFG, Gly-Leu-PheGly, is a tetrapeptide that is also widely used as enzymeactivated linker (Luo, Yang, Kope Ckov, & Rich Kope,
2011; Vicent et al., 2005; R. Zhang, Yang, Sima, Zhou,
& Kopecek, 2014). Another enzyme-sensitive linker is
N-acetyl-Gly-D-ala-L-Phe-L-Lys that can be degraded
by both proteases plasmin and cathepsin B (Barthel et
al., 2012).
Glutathione (GSH) levels in human tissue vary greatly,
but they tend to be elevated in breast, ovarian, head
and neck and lung tumors, compared to normal tissue
(Gamcsik, Kasibhatla, Teeter, & Colvin, 2012). Due to
this finding, disulfide bond can be a linker for targeted
drug release which will undergo cleavage through a
reduction reaction (Wong & Choi, 2015). This has been
used in synthesis of various polymer drug conjugate
such as PEG-co-tert butyl acrylate-paclitaxel (Chen
et al., 2012), PEG-camptothecin (Li et al., 2011), and
chitosan oligosacharide-doxorubicin (Su et al., 2015).
However, there are some limitations in using disulphide
linker such as low drug payload, low physical stability
and possibility of change in chemical structure of the
drugs after being released, and therefore requires further
studies on destabilization and preclinical evaluation
(Chang et al., 2016).
Required Characteristics of the Polymer
Water Solubility and Reactive Functional Groups
Functional groups of polymer play some important roles.
They determine polymer properties in solution, including
solubility, and also provide reactivity for conjugation
with other molecules. Normally, natural polymers have
hydroxyl (-OH) and /or carboxylic (-COOH) groups.
Chitosan is one of natural polymers that has primary
amine (-NH2) group. Those functional groups provide
hydrophilicity as well as reactivity for conjugation
reaction. However, some natural polymers, such as
starch and original cellulose that mainly consist of –OH
groups, are not water soluble. Their insolubility in water
is suspected due to strong intermolecular hydrogen
bonds or hydrophobic interaction (Medronho, Romano,
Miguel, Stigsson, & Lindman, 2012). Therefore, the
choice of natural polymers candidate for a drug conjugate
should be based on not only their available functional
ISSN 2407-2354
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Figure 2. Structure of Some Water-soluble Natural Polymers
groups but also their solubility in water. Below are some
water-soluble natural polymers that have been studied
as carrier in polymer-drug conjugates. The structure of
each polymer can be seen in Figure 2.
Dextran. Dextran is a polymer of α-ᴅ-glucopyranosyl
with (1,6)-linked α-ᴅ-glucopyranosyl unit (BeMiller,
2003). Dextran is synthesized from sucrose by certain
lactic-acid bacteria, the best known are Leuconostoc
bacteroides and Streptococcus mutans. Dextran is
normally used as plasma volume expander (Svens &
Rodhe, 2013).
Dextran is probably the most investigated natural
polymer derivate in polymer-drug conjugates, which
has been developed for various types of disease. For
example, daptomycin-dextran conjugates showed higher
affinity for fibrinogen than free daptomycin, suggesting
improvement of daptomycin efficacy in endocarditis
(Muangsiri & Kirsch, 2006). Varshosaz et al. (2011)
synthesized budenoside-dextran conjugate as colontargeted drug delivery system for ulcerative colitis
medication. Cathecin, a flavonoid, was also conjugated
to dextran for the treatment of pancreatic ductal
adenocarcinoma (Vittorio et al., 2012).
Dextrin. Dextrins are a group of oligosaccharides which
derived from partial hydrolysis of acid or amylases
action (BeMiller, 2003). It is a mixture of ᴅ-glucose unit
polymer linked by (1,4) or (1,6) glycosidic bonds (Y.
Zhao & Tu, 2013). Corn starch is generally used as the
most common sources of dextrins due to its availability in
nature and its low production cost, even though starches
from potato, tapioca and sago are considered easiest to
ISSN 2407-2354

be converted to dextrins (Baumann & Conner, 1994).
As carrier in drug delivery system, they are usually
modified into succinoylated-dextrin which undergo
slower rate of degradation by pancreatic α-amylase
(Hreczuk-Hirst, Chicco, German, & Duncan, 2001).
Hardwicke et al., (2008) used succinoylated-dextrin as
carrier for recombinant human epidermal growth factor
(rhEGF) for wound healing. The conjugates showed
elevated stability against degradation by trypsin and
neutrophil elastase. Succinoylated-dextrin was also used
to conjugate an antitumor protein, phospholipase A2
(PLA2), as synthesized by Ferguson & Duncan (2009).
The conjugate showed lower PLA2’s hemolytic activity
with similar, or higher, cytotoxicity against MCF7, HT29, and B16F10 cells, compared to free PLA2.
Ferguson, Azzopardi, Roberts, Walsh, & Thomas (2014)
successfully synthesized dextrin-colistin conjugates.
Although the conjugates diminished the antimicrobial
activity of colistin, they showed prolonged plasma
retention and reduced toxicity, in comparison to colistin
sulfate.
Pullulan. Pullulan is a natural-derived consisted of
maltotrioses, linked by α-(1,6)glycosidic bond, which
consists of three molecules of glucose linked to each
other with α-(1,4) glycosidic bond (Chiellini, Piras,
Errico, & Chiellini, 2008; dos Santos & Grenha, 2015;
Mizrahy & Peer, 2012; Namazi, Fathi, & Heydari,
2012; Singh, Kaur, Rana, & Kennedy, 2017). This
structure is suggested to give pullulan high flexibility
and water solubility (Kumar, Saini, Pandit, & Ali, 2012;
Trinetta & Cutter, 2016). Pullulan is an extracellular
polysaccharide. It was first reported from the strains of
fungus Aureobasidium pullulans (Bender, Lehmann,
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& Wallenfels, 1959; Park & Khan, 2009). The fungus
cultivation parameters strongly affect the resulting
pullulan MW, which is usually ranging from 4.5 x 104
– 6 x 105 Da (Cheng, Demirci, & Catchmark, 2011; dos
Santos & Grenha, 2015).
In a research by Zhang et al. (2011), pullulandoxorubicin conjugate showed greater toxicity
(determined by IC50) toward ovarian carcinoma A2780
cells compared to free drugs after 48 hours incubation.
Scomparin, Salmaso, Bersani, Satchi-Fainaro, &
Caliceti (2011) demonstrated opposite result, where
the polymer conjugation showed lower toxicity than
free doxorubicin. However, the conjugates showed
significant improvement in pharmacokinetics, with halflife (T1/2β) ~4 times longer than the parent drug. Beside
drug, pullulan was also used to synthesized conjugates
that bring gadolinium diethylene triamine pentaacetate
(Gd-DTPA) for contrast agent in MRI (Yim et al., 2011).
The conjugates showed high accumulation in the liver,
which suggests hepatocyte-specific MRI contrast agent.
Chitosan. Chitosan is a polymer obtained from
partial N-deacetylation of chitin, found in crustacean
shells (Emeje & Anwunobi, 2011; Hamed, Özogul,
& Regenstein, 2016). Chitosan and chitin structure is
similar to cellulose. In chitin and chitosan, the hydroxyl
at C-2 position replaced by acetamide groups (Islam,
Bhuiyan, & Islam, 2017). Chitosan is composed of
N-acetyl glucosamine and glucosamine residues which
covalently linked by linear β-(1,4) glycosidic bonds
and obtained by transforming its acetamide groups into
primary amino groups (Hamed et al., 2016; Islam et al.,
2017).
Chitosan has been widely explored in gene delivery.
The positively charged amino group of chitosan can
create electrostatic attraction with the negatively
charged nucleic acid to make a complex and therefore
can protect the gene from plasma nucleases (Saranya,
Moorthi, Saravanan, Pandima Devi, & Selvamurugan,
2010). However, chitosan now is also used for wider
application. For example, conjugates of N-succinylchitosan and carboxymethyl-chitin with chemotherapy
drug mitomycin C (MMC) for slow release MMC (Song,
Onishi, & Naai, 1992). Other example is conjugation
of paclitaxel to low molecular weight chitosan, as
synthesized by Lee et al. (2008), that showed ~42%
per oral bioavailability and increased solubility,
suggesting the possibility to deliver paclitaxel via oral
route. Chitosan was also used to carry near infra red
(NIR) dye IR820 for cancer theranostic application
(Srinivasan, Manchanda, Fernandez-Fernandez, Lei, &
Mcgoron, 2013). Conjugation of exendin-4, a GLP-1
mimetic peptide for treatment of type 2 diabetes, to low
molecular weight chitosan showed improved stability
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against trypsin and better oral pharmacokinetics profile
(Ahn et al., 2013). These findings indicate the prospect
to create an orally bioavailable peptide drugs.
Hyaluronic Acid. Hyaluronan is an international
nomenclature of heteropolysaccharides attributed to
Endre Balazs. It encompasses the term of two different
forms of the molecule e.g. the acid form, hyaluronic acid;
and its salt, hyaluronate, such as sodium hyaluronate
(Balazs, Laurent, & Jeanloz, 1985). At physiological
pH, its carboxyl groups form anionic charge and
balanced with cation such as sodium, potassium,
calcium or magnesium (Fallacara, Baldini, Manfredini,
& Vertuani, 2018). Hyaluronan is an extracellular
matrix compound. It is a highly molecular weight
glycosaminoglycans, composed of disaccharide repeats
of N-acetylglucosamine and glucoronic acid linked
together by alternating β-(1,4) and β-(1,3) glycosidic
bonds (Necas, Bartosikova, Brauner, & Kolar, 2008).
The number of repeating disaccharides in a hyaluronan
can achieve 10,000 or more with molecular mass about
4 million Dalton (Cowman & Matsuoka, 2005; Necas et
al., 2008).
Homma et al. (2010) optimized hyaluronic acidmethotrexate conjugates formulation to obtain best
characteristic for ostheoarthritis treatment. Conjugation
with hyaluronic acid can also enhance solubility of
curcumin as shown by Manju & Sreenivasan (2011). Like
other natural polymers mentioned before, hyaluronic
acid has also been employed as carrier for paclitaxel
(H. Lee, Lee, & Park, 2008; Yin et al., 2015; D. Zhao,
Zhang, Yang, He, & Luan, 2016).
Pectin. Pectins are a member of polysaccharides
which commonly present in primary cell walls and
middle lamella of dicotyledonous and non-grass
monocotyledonous plants (Gawkowska, Cybulska,
& Zdunek, 2018). Pectins are mainly consisted of
covalently linked galacturonic acid by linear chain
α-(1,4) glycosidic bonds that forms the backbone
of pectin, homogalacturonan (Human Metabolomic
Database, 2018; Mohnen, 2008; Wishart et al., 2018).
The fine structures of its polysaccharides are never
fully known or defined, and at first were thought to be
triad homopolymers i.e. homogalacturonan, arabinan
and galactan. Afterward, the reports from various plant
materials showed that pectic subtances is a group of
complex and diversified polysaccharides, with molecular
weight more than 200.000 Dalton, which correspond to
polymerization degree (Flutto, 2003; Yapo, 2011).
Pectin, depending on the degree of esterification,
has carboxylic groups. In this case, the degree of
esterification (DE) of pectin affects many properties
of pectin polymer, i.e. gelling properties, and therefore
ISSN 2407-2354
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affects its functionality (Lutz, Aserin, Wicker, & Garti,
2009; Morris, Kok, Harding, & Adams, 2010).
Tang et al. (2010) synthesized pectin-adriamycin
conjugate which exhibited remarkable therapeutic
effect on melanoma pulmonary metastasis a (B16
cell line) in C57BL/6 mice (shown by lung histology
and percent of survival after 60 days tumor implant).
Cheewatanakornkool, Niratisai, Manchun, Dass,
& Sriamornsak (2017) also used the same drug to
conjugate with thiolated pectin. The conjugates were
then crosslinked by ionotropic gelation technique to
produce microbeads with particle size ~1000 μm.
Arabinogalactan. Arabinogalactan is a water-soluble
polysaccharide that is found in various plants such as
Cuscuta chinensis, Larix occidentalis, Larix sibirica
and many more (Paulsen & Barsett, 2005). It has some
bioactive properties such as effects on macrophages,
T-lymphocytes and NK-cells (Paulsen & Barsett, 2005).
The (1,3)-linked β-ᴅ-galactopyranose units [→3)-β-ᴅGalp-(1→] build the main chain, with branching points
at the C6 atom (Mikhailenko et al., 2016). The branching
consists of 3,6-di-O-substituted and 6-O-substituted
galactopyranosyl, 3-O-substituted arabinofuranosyl
residues, as well as arabinofuranosyl, arabinopyranosyl
and galactopyranosyl non-reducing terminal units.
In a study conducted by Pinhassi et al. (2010),
arabinogalactan was used to create targeted delivery and
target-activated release of methotrexate, with folic acid
as targeting moiety. The conjugate exhibited elevated
cytotoxicity against folate receptor (FR)-overexpressing
cells compared to FR-lacking cells. Elgart, Farber,
Domb, Polacheck, & Hoffman (2010) compared low
molecular weight (L-Mw) and high molecular weight
(H-Mw) arabinogalactan as carrier for amphotericin B.
The result showed altered pharmacokinetics parameters
of conjugates compared to free amphotericin B,
where conjugation of amphotericin B with H-Mw
arabinogalactan showed significant decreased in volume
of distribution and clearance. Arabinogalactan was also
used to carry gadolinium-diethylenetriaminepentaacetic
acid for liver-specific MRI contrast agent (Li et al.,
2008).
Molecular Weight and Dispersity
Molecular weight plays an important role in
nanoparticle’s behavior in the body. As mentioned
before, in order to exhibit prolonged plasma circulation,
a polymeric carrier should be larger than 40 kDa, which
is the threshold of renal clearance (Fang et al., 2011). In
case of hydrodynamic size, the size should be maintained
5.5 – 150 nm to avoid renal clearance (Choi et al., 2007)
as well as to escape phagocytic uptake (He, Hu, Yin,
Tang, & Yin, 2010).
ISSN 2407-2354
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Dispersity (Ð, pronounced “D-stroke”), which replaces
the misleading but widely used term “polydispersity
index”, is “dispersions of distributions of molar masses
(or relative molecular masses, or molecular weights) and
degrees of polymerization” (Stepto, 2010). In a simple
way, dispersity is the ratio between weight average
molecular weight and number average molecular weight
(Mw/Mn). Dispersity index of a highly uniform polymer
is 1, and this can only be obtained by protein. Other type
of polymers have dispersity more than 1. For polymerdrug conjugates, the dispersity of the polymeric carrier
should be as close as 1.
When using polymer as excipient in drug dosage form,
dispersity index is not essential. On the other hand, for
polymers that are “therapeutically active” like polymerdrug conjugates, the dispersity, which correlates with
molecular weight distribution, becomes important. First,
from the conjugation reaction point of view, dispersity
is important to determine the stoichiometry. Broad
dispersity means broad molecular weight distribution,
which also means vary individual chain length. If this
exists, it will be difficult to determine the molar ratio
between polymer and drugs in the conjugation reaction.
Second, from the therapeutic dose point of view,
dispersity is essential to determine the dose. The number
of drug molecules per polymer chain should be well
defined to ensure the proper therapeutic dose.
The challenge of using natural polymer as carrier in
polymer-drug conjugates is the wide range of molecular
weight, depending on the sources. For example,
arabinogalactan from gum Arabic, mango fruit exudate,
and larch have Mn 71.6 kDa, 19.8 kDa, and 8.85 kDa,
respectively (Nagel, Conrad, Leitenberger, Carle, &
Neidhart, 2016). Chitosan sold by Sigma-Aldrich is
available in wide variety of molecular weight, ranging
from 5 to 375 kDa. Therefore, researcher need to predefine the molecular weight and origin of the natural
polymers prior to use it.
Technical Aspect on Synthesis and Analysis
Conjugation of Drugs and Targeting Moieties to
Polymeric Carrier
Many conjugation techniques can be an option. The
choice of conjugation technique depends on the
functional groups present on both polymer and the small
molecule (Hermanson, 2013). Moreover, the functional
groups should be available and chemically compatible
to make the reaction possible (Hermanson, 2013).
Meanwhile, polymer chain in solution tend to form
random, three-dimensional coil (Edvinsson, 2002). This
conformation becomes a great challenge in conjugation
reaction between polymer and small molecule because
some of the reactive groups in polymer are hindered
inside the conformation and inaccessible.
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Different technique of conjugation are available for each
kind of linkage. Generally, amide and ester are the most
used for small molecule drugs, while thiol conjugation is
more common for protein and peptide drugs. Therefore,
in this review we will focus on the amide or ester
conjugation reaction.
Amide bonds are basically created from condensation of
carboxylic acids and amines. However, the reaction does
not occur spontaneously at room temperature. It needs
activation of carboxylic acid by converting the –OH of
the acid into a good leaving group (Valeur & Bradley,
2009). Once it is activated, the amines will be easier to
replace the –OH of the acid to form amide bond.
Activation of carboxylic acids needs coupling reagents
and the choice of coupling reagent is essential for
the success of reaction. Carbodiimides were the first
coupling agents to be synthesized and are still widely
used. They are called as zero-length crosslinking
agent because no additional chemical is incorporated
between the conjugated molecules (Hermanson, 2013).
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N-substituted carbodiimides can react with carboxylic
acids to form o-acylisourea derivatives (Figure 3). This
o-acylisourea intermediate is a highly reactive species
and can be replaced by a nucleophile such as a primary
amine to form an amide bond. There are three well-known
carbodiimide derivates: dicyclohexylcarbodiimide
(DCC), diisopropylcarbodiimide (DIC), and 1-ethyl-3(3-dimethylaminopropyl)carbodiimide hydrochloride)
(EDC). DCC and DIC are water-insoluble reagents and
thus can only be used for reaction in organic solvent.
EDC is water soluble and therefore suitable for aqueousbased reaction. Addition of sulfo-NHS ester is sometimes
required to reduce early hydrolysis of active carboxylates
and thus increase the conjugation efficiency.
Ester bond formation uses the same principle as
amide. However, it requires catalytic agent such as
dimethylaminopyridine (DMAP). Addition of DMAP
brings formation of acyl pyridinium intermediate which
then reacts with alcohol to form ester product as shown
in Figure 3 (Lutjen, Quirk, Barbera, & Kolonko, 2018).

Figure 3. General Mechanism of Amide and Ester Formation Using Carbodiimide as
Coupling Agent (adapted from Hermanson, (1996) & Lutjen, Quirk,
Barbera, & Kolonko (2018))
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Analytical Technique
Size Exclusion Chromatography. Size exclusion
chromatography
(SEC)
or
gel
permeation
chromatography (GPC) is basically one type of
high performance liquid chromatography (LC). The
fundamental difference between SEC and HPLC is in the
principle of molecule separation. While HPLC separates
molecules based on their hydrophilicity-hydrophobicity
nature, SEC dissociates molecules solely based on their
size. SEC uses columns packed with very small, round,
porous particles which are made from insoluble crosslinked polymers or inorganic materials, such as spherical
silicas (Agilent, 2015).
As mentioned before, when dissolved in a solvent,
polymer chain will coil up to form a ball of string. Inside
the SEC column, the polymer conformation will behave
like spheres. The size of the sphere is molecular weight
dependent, where higher molecular weight polymer
will form larger spheres. When the polymer coils pass
through the porous beads in SEC column, those that are
bigger than the largest pores in the beads are not able
to enter the pores and therefore exit the column first.
The medium size polymer coils can probably enter the
biggest pores, but not the small ones. As a result, these
coils will exit later than the larger ones. The smallest
polymer coils can occupy any pores in the beads and
therefore will be retained much longer. As the fractions
exit the column, they are measured by certain detector
(mostly refractive index detector) and then compared
with calibration standard (e.g. polystyrene). The elution
profile of the sample will be displayed in chromatogram.
Illustration of SEC mechanism is shown in Figure 4.
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With SEC, the value of Mn, Mw and dispersity can be
obtained and thus, SEC becomes the most regularly used
method for molecular weight determination of polymers.
Nuclear Magnetic Resonance. Nuclear magnetic
resonance (NMR) spectroscopy is a well-established
method for the characterization of molecules, including
polymers. It has been applied for the determination
of polymerization conversion and kinetics (Favier,
Charreyre, & Pichot, 2004; Martin, Gody, & Perrier,
2015), monomer sequence in copolymer (Hatada &
Kitayama, 2004), molecular weight of polymer (Izunobi
& Higginbotham, 2011) and successful conjugation of
drug to polymer (Hu et al., 2014; Lv et al., 2014). 1HNMR
spectroscopy is considered as a fast, reproducible, and
relatively simple technique for polymer-drug conjugates
structure elucidation.
Mass Spectrometry. Large molecules have triggered
progress development of efficient ionization methods for
mass spectrometric analysis especially in the structural
analysis of biomacromolecules. These were overcome
first by fast atom bombardment (FAB), and since the
late 1980s more efficiently by electrospray ionization
(ESI) and matrix-assisted laser desorption/ionization
(MALDI) (Aminlashgari & Hakkarainen, 2011). The
application of ESI and MALDI have been widely
applied for biomolecules of oligo- and polymeric size,
in combination with appropriate mass analyzers such as
instruments, quadrupoles, ion traps, and time-of-flight
tubes (Aminlashgari & Hakkarainen, 2011). To be more
attractive, the techniques are also combined with tandem
mass spectrometry.

Figure 4. Illustration of Polymer Separation by GPC
(adapted from Agilent Technologies Inc., (2015))
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Table 1. Common Amines for labeling by Iminium Ion Formation (Harvey, 2000)
No

Amine

Abbreviation

Mass Increment

1

2-aminobenzamide

2-AB

120

Structure
O

NH2

NH2

2

2-aminopyridine

2-AP

78

3

2-aminoacridone

2-AMAC

194

N

NH2

O
NH2

N
H

4

3-aminoquinoline

3-AQ

128

N

NH2

5

4-aminobenzoic
acid methyl ether

ABME

135

O

O

H2N

6

4-aminobenzoic
acid ethyl ether

ABEE

149

O

O

H 2N

7

4-aminobenzoic
acid n-butyl ester

ABBE

176

O

O

H 2N

8

4-amino-N-(2-diethylaminoethyl)-benzamide

DEAEAB

219

O
N
N
H
H 2N

Analysis of polymer and biomacromolecule are suitable
with soft ionization mass spectrometric techniques.
There are two approaches for analyzing polymer (1)
Top-down approach; polymer was analyzed for its
higher-order structure. For top-down approach matrixassisted laser desorption/ionization-mass spectrometry
(MALDI-MS) was widely used; (2) Bottom-up
approach; polymer was cut into smaller fragments
of oligomer and reconstructed back into its original
form. For bottom-up electrospray ionization-mass
spectrometry (ESI-MS) has been excellent techniques
for the analysis of the synthetic polymer. For high
molecular mass polymer analysis, MALDI-MS is the
best choice because of its soft ionization. Soft ionization

was achieved by the interaction between the matrix
and the polymer. MALDI-MS makes polymers can be
analyzed in their original structure. Thus, it is possible
to acquire more information about structural differences
among polymers. Liquid chromatography equipped with
ESI-MS is the best choice for monomer analysis of the
polymer.
When dealing with polymers with high molecular
mass distribution, ESI-MS can create multiple charged
ion adducts that can be a problem. Carbohydrates
commonly form alkali adducts. Also, compared to
proteins and peptides, poly- or oligosaccharides show
lower surface activity, higher polarity, and are less stable.
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Figure 5. Iminium Ion Formation of β-glucose and 2-aminobenzamide
(Unterieser, 2011)
Carbohydrates alkali adducts often show dispersity
of molecular mass and chemical structure, and due to
many stereochemical centers have isobaric ions, which
cannot easily be differentiated by MS. The drawback
with MALDI is the difficulty in studying these low
mass range and often makes it impossible to detect low
molecular weight compounds.
The presence of charged species determined MS
analysis. Although both positive and negative ion can
run simultaneously, positive mode is more common and
therefore preferentially chosen. Carbohydrate is generally
neutral and, apart from amino sugars, possess no basic
groups that are able to be protonated. More common
is, thus, the information of adducts with metal cations,
mainly alkali ions, and preferentially the presence of
sodium ion. Ion yield and the sensitivity of MS depend
on appropriate coordination sites. The oxygen atoms
achieve coordination with their nonbonding electron
pairs (Crecelius, Vitz, & Schubert, 2014).
Chemical modification is the selective incorporation of
a tag which has a readily ionizable functional group,
often a quaternary ammonium group. Also, most of
the tags are chromophores, and some of them are also
fluorescent, which is useful for parallel detection in
liquid chromatography. The most popular reactions are
imines, and usually followed by a reduction to transfer
the reversibly formed intermediate imines to the stable
amines (Crotty, Gerişlioğlu, Endres, Wesdemiotis, &
Schubert, 2016). Figure 5 shows the reaction between
β-glucose with 2-aminobenzamide forming the iminium
ion which can be detected by MS using positive ion
ISSN 2407-2354

mode. Several reagents were used to produce iminium
ion as described in Table 1.
a. Linear homopolymer analysis using thermal-MS
techniques
Thermal-MS techniques can decompose polymer by
heat. Afterward, polymers are then analyzed by mass
spectrometer to observe the degradation product of the
polymer. Characterization of the temperature-dependent
degradation product is useful to obtain information
regarding both physical and structural properties. It is
reported that simultaneous thermogravity-differential
thermal analysis coupled with miniaturized ion trap
MS allowed precise real-time monitoring analysis of
activated organic compounds such pas pyrolysates.
These features allow a better understanding of the
complex thermal behavior and the precise pyrolysates
material (Paine, Barker, & Blanksby, 2014; Wang, 1999).
b. Linear copolymer analysis using direct MS/MS
techniques
Polymer sample can be directly injected to the mass
spectrometer without preparation. The analyte ions are
then fragmented to give more detailed structural and/
or architectural information. The tandem MS analysis
can be executed using various scanning modes such
as selective ion monitoring (SIM), precursor ion scan,
selected reaction monitoring, and multiple reaction
monitoring (MRM). Out of all these modes, selective ion
monitoring is one of the most common MS/MS modes to
characterize the structure of various synthetic polymers.
During this mode, a precursor analyte ion is isolated,
followed by activation and fragmentation inside the
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Figure 6. Analytical Workflow of Oligosaccharide-imine Conjugate
mass spectrometer. Finally, all fragmentation products
are scanned and analyzed for more detailed investigation
of the precursor ion structure (Crotty et al., 2016; Paine
et al., 2014).
c. Complex polymer analysis using LC-MS based
techniques
It has been proven that there are some cases where MS
alone is insufficient for a comprehensive characterization
of end groups, copolymer composition sequences, etc.
Therefore, some techniques have been developed to
obtain a more detailed polymer characterization, which
involve hyphenation with HPLC either separating
by polarity or size or 2D-LC. Many different 1D-LC
systems hyphenated with MS are reported, particularly,
for optimizing the transfer of the sample from a
chromatographic system to the mass spectrometer.
The main advantage of ESI is its compatibility with
continuous hyphenation to diverse HPLC modes in
comparison to MALDI, where most of the hyphenation
techniques are carried out offline. Different hyphenations
and different detectors are used to obtain extra knowledge
about polymers, such as chemical heterogeneity and
isomeric architecture (Sarrut, Crétier, & Heinisch, 2014).
Therefore, enabling the chemist to improve synthetic
routes.

A 2D (RP-LC X SEC) chromatography system can also
be tandemed with MALDI and ESI. The procedure is
fully automated and very versatile. The RP-LC X SEC
combination appears to be one of the most important
analytical methods when specific conditions are applied
in the first dimension (Trathnigg, 1995). Figure 6 shows
analytical workflow of oligosaccharide conjugated with
amine to form imine.
d. Complex polymer analysis using ion mobility-MS
(IM-MS) techniques
IM spectrometry provides an additional dimension for
elucidating different conformations or architectures
present in an analyte. With IM-MS, gas phase ions are
separated based on their mobility and composition.
Information obtained by IM separation can be used
to create collision cross-sections, which are directly
related to the macromolecular shape. Isobaric ions are
two different chemical species with different elemental
composition, having the same nominal mass (mass
difference at ppm level). They often appear in polymer
analysis and can only be resolved by high-resolution
spectra. If isobaric species are not solved, obtaining
a detailed structural characterization with MS/MS
experiments can be very challenging. This can result in
very complicated MS/MS data, having fragment ions from
both species in the same spectrum (Crotty et al., 2016).

Figure 7. Some Techniques to Purify Polymer-Drug
Conjugates: (a) Precipitation, (b) Dialysis, (c) Ultrafiltration by
Centrifugation, and (d) Desalting Column
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Purification of Conjugates
Pure conjugates are required for in vitro and in vivo
studies in order to avoid false positive or negative. The
conjugates must not contain free unreacted drugs that
can bias the in vitro and in vivo study results. There are
some purification technique that can be used to separate
conjugates and the unreacted drugs, which include
precipitation, dialysis and desalting column.
Precipitation is one simple way to isolate and purify
polymers from small molecules. The technique needs a
solvent that is “poor” for the polymer and “good” for
the drug. A solution that contains a mixture of polymer
and free drugs is then poured into the “poor” solvent,
leading to precipitation of the polymer while leaving the
free drugs in supernatant (see Figure 7a).
Dialysis involves a semi-permeable membrane with
certain molecular weight cut off (MWCO). The principle
is basically retention of molecules larger than MWCO
in the donor compartment, while all molecules smaller
than MWCO pass through the membrane into the
acceptor compartment (Figure 7b). The migration of
the molecules from donor to acceptor compartment will
reach equilibrium, a condition where the concentration
of the molecules in donor compartment is equal to that
in acceptor compartment. In equilibrium state, there
will be no more diffusion of the molecules through
the membrane because of concentration gradient. The
solvent in acceptor compartment must be regularly
replaced with the new one in order to maintain the
concentration gradient, and therefore allow the diffusion
of the small molecules.
Other technique that adopts the principle of dialysis
is ultrafiltration by centrifugation (Figure 7c). This
technique requires centrifugation tube, which consists of
two membrane-separated compartments. The membrane
is also semipermeable and has MWCO. The solution of
conjugates and drugs mixture is placed in the upper part of
the tube (donor compartment), and then centrifuged. The
centrifugation force will pull down the solvent through
the membrane, together with the molecules smaller than
MWCO and the solution residue that contains conjugates
will stay in the upper part. By adding a new solvent to
the donor compartment, and repeat the centrifugation for
several times, pure conjugates can be obtained.
Desalting column is also a versatile tool to purify
macromolecules. The principle of desalting column
is basically similar to size exclusion chromatography,
which is separation based on the molecular size. The
solution of conjugates and drugs mixture is passed
through the column and then the eluted fractions are
collected (Figure 7d). All fractions are then analyzed,
e.g. by HPLC, to confirm which fractions contain
conjugates.
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CONCLUSION AND FUTURE PERSPECTIVE
Natural polymers are potential candidate for carrier in
drug delivery system. There are numerous studies in
polymer therapeutic using natural polymer. However,
we have not found any international publication in this
field from Indonesian researcher. Therefore, we would
like to encourage Indonesian researcher to explore this
area, which includes production of pure natural polymer
with well-defined characteristic, synthesis of polymerdrug conjugate to improve the efficacy of commercially
available drugs, in vitro and in vivo study of the
conjugates, as well as clinical study. Technical aspects
in synthesis and analysis might become challenges
due to limited facilities and analytical instruments. For
example, Nuclear Magnetic Resonance (NMR) is not
commonly available in every research institution. There
are only few institutions in Indonesia that have NMR
facility, including Research Center for Chemistry LIPI
(Serpong), Universitas Gadjah Mada (Yogyakarta),
Airlangga University (Surabaya), and Bandung Institute
of Technology (Bandung). Therefore, collaboration
between institutions, as well as government role
in mapping and providing the required analytical
instruments and facilities, are essential. Furthermore,
collaboration between different experts, including
medicinal chemists, organic chemists, pharmacists and
clinicians, is also utmost important.
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